Panbronchiolitis

Encyclopedia of Respiratory Medicine, Four-Volume Set

Volumn , Issue , 2006, Pages 297-300

  Epler, G R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chronic sinusitis; Diffuse panbronchiolitis; Macrolides; Pseudomonas

Indexed keywords

EID: 85027915687     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-12-370879-6/00050-8     Document Type: Chapter

References (15)

1. Epler G.R., Colby T.C. Bronchiolitis obliterans and other bronchiolar airflow disorders. Bone's Atlas of Pulmonary and Critical Care Medicine 2001, 65-76. Lippincott Williams & Wilkins, Philadelphia. 2nd edn. G.D. Campbell, D.K. Payne (Eds.).
2. Gomi K., Tokue Y., Kobayashi T., et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest 2004, 126:95-99.
3. Hiratsuka T., Mukae H., Iiboshi H., et al. Increased concentrations of human β-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Thorax 2003, 58:425-430.
4. Homma H., Yamanaka A., Taniomoto S., et al. Diffuse panbronchiolitis. a disease of the transitional zone of the lung. Chest 1983, 83:63-69.
5. Kadota J., Mukae H., Fujii T., et al. Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 2004, 125:1239-1247.
6. Kadota J., Mukae H., Ishii H., et al. Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respiratory Medicine 2003, 97:844-850.
7. Kim J.H., Jung K.H., Han J.H., et al. Relation of epidermal growth factor receptor expression to mucus hypersecretion in diffuse panbronchiolitis. Chest 2004, 126:888-895.
8. Kudoh S., Azuma A., Yamamoto M., et al. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. American Journal of Respiratory and Critical Care Medicine 1998, 157:1829-1832.
9. Matsuzaka Y., Tounai K., Denda A., et al. Identification of novel candidate genes in the diffuse panbronchiolitis critical region of the class I human MHC. Immunogenetics 2002, 54:301-309.
10. + cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. American Journal of Respiratory and Critical Care Medicine 1995, 152:613-618.
11. Park S.J., Lee Y.C., Rhee Y.K., Lee H.B. The effect of long-term treatment with erythromycin on Th1 and Th2 cytokines in diffuse panbronchiolitis. Biochemical Biophysical Research Communications 2004, 324:114-117.
12. Poletti V., Chilosi M., Casoni G., Colby T.V. Diffuse panbronchiolitis. Sarcoidosis Vasculitis and Diffuse Lung Diseases 2004, 21:94-104.
13. Rubin B.K., Henke M.O. Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 2004, 125(supplement 2):70S-78S.
14. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 2004, 125(supplement 2):41S-51S.
15. Wozniak D.J., Keyser R. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004, 235(supplement 2):62S-69S.